Risk factors for symptomatic vascular events in giant cell arteritis: a study of 254 patients with large-vessel imaging at diagnosis

被引:9
作者
de Mornac, Donatienne [1 ]
Agard, Christian [1 ]
Hardouin, Jean-Benoit [2 ,3 ,4 ]
Hamidou, Mohamed [1 ]
Connault, Jerome [1 ]
Masseau, Agathe [1 ]
Espitia-Thibault, Alexandra [1 ]
Artifoni, Mathieu [1 ]
Ngohou, Chan [5 ]
Perrin, Francois [6 ]
Graveleau, Julie [6 ]
Durant, Cecile [1 ]
Pottier, Pierre [1 ]
Neel, Antoine [1 ]
Espitia, Olivier [1 ]
机构
[1] CHU Nantes, Dept Internal Med, 1 Pl Alexis Ricordeau, F-44093 Nantes, France
[2] Nantes Univ, UMR 1246 SPHERE, INSERM, Nantes, France
[3] Tours Univ, Tours, France
[4] Nantes Univ Hosp, Methodol & Biostat Platform, Nantes, France
[5] Nantes Univ Hosp, Dept Med Informat, Nantes, France
[6] St Nazaire Hosp, Dept Internal Med, St Nazaire, France
关键词
aortitis; giant cell arteritis; large-vessel imaging; risk factors; vascular event; COMPLICATION AORTIC-ANEURYSM; CARDIOVASCULAR-DISEASE; TEMPORAL ARTERITIS; POPULATION; INFLAMMATION; DISSECTION; METHOTREXATE; MORTALITY; STENOSIS; PET/CT;
D O I
10.1177/1759720X211006967
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: To identify factors associated with vascular events in patients with giant cell arteritis (GCA). Methods: We performed a retrospective study of GCA patients diagnosed over a 20-year-period, who all underwent vascular imaging evaluation at diagnosis. Symptomatic vascular events were defined as the occurrence of any aortic event (aortic dissection or symptomatic aortic aneurysm), stroke, myocardial infarction, limb or mesenteric ischemia and de novo lower limbs arteritis stage 3 or 4. Patients with symptomatic vascular event (VE+) and without were compared, and risk factors were identified in a multivariable analysis. Results: Thirty-nine (15.4%) of the 254 included patients experienced at least one symptomatic vascular event during follow-up, with a median time of 21.5 months. Arterial hypertension, diabetes, lower limbs arteritis or vascular complication at diagnosis were more frequent in VE+ patients (p < 0.05), as an abnormal computed tomography (CT)-scan at diagnosis (p = 0.04), aortitis (p = 0.01), particularly of the descending thoracic aorta (p = 0.03) and atheroma (p = 0.03). Deaths were more frequent in the VE+ group (37.1 versus 10.3%, p = 0.0003). In multivariable analysis, aortic surgery [hazard ratio (HR): 10.46 (1.41-77.80), p = 0.02], stroke [HR: 22.32 (3.69-135.05), p < 0.001], upper limb ischemia [HR: 20.27 (2.05-200.12), p = 0.01], lower limb ischemia [HR: 76.57 (2.89-2027.69), p = 0.009], aortic atheroma [HR: 3.06 (1.06-8.82), p = 0.04] and aortitis of the descending thoracic aorta on CT-scan at diagnosis [HR: 4.64 (1.56-13.75), p = 0.006] were independent predictive factors of a vascular event. Conclusion: In this study on GCA cases with large vessels imaging at diagnosis, aortic surgery, stroke, upper or lower limb ischemia, aortic atheroma and aortitis of the descending thoracic aorta on CT-scan, at GCA diagnosis, were independent predictive factors of a vascular event.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Large-vessel giant cell arteritis: diagnosis, monitoring and management
    Koster, Matthew J.
    Matteson, Eric L.
    Warrington, Kenneth J.
    RHEUMATOLOGY, 2018, 57 : 32 - 42
  • [2] Advances in large-vessel imaging and its current place in the diagnosis and follow-up of large-vessel giant cell arteritis
    Liozon, E.
    REVUE DE MEDECINE INTERNE, 2019, 40 : A16 - A19
  • [3] Large-vessel giant cell arteritis: a cohort study
    Muratore, Francesco
    Kermani, Tanaz A.
    Crowson, Cynthia S.
    Green, Abigail B.
    Salvarani, Carlo
    Matteson, Eric L.
    Warrington, Kenneth J.
    RHEUMATOLOGY, 2015, 54 (03) : 463 - 470
  • [4] Large-vessel involvement in giant cell arteritis and polymyalgia rheumatica
    Muratore, F.
    Pazzola, G.
    Pipitone, N.
    Boiardi, L.
    Salvarani, C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (02) : S106 - S111
  • [5] Large-vessel involvement and aortic dilation in giant-cell arteritis. A multicenter study of 549 patients
    de Boysson, Hubert
    Daumas, Aurelie
    Vautier, Mathieu
    Parienti, Jean-Jacques
    Liozon, Eric
    Lambert, Marc
    Samson, Maxime
    Ebbo, Mikael
    Dumont, Anael
    Sultan, Audrey
    Bonnotte, Bernard
    Manrique, Alain
    Bienvenu, Boris
    Saadoun, David
    Aouba, Achille
    AUTOIMMUNITY REVIEWS, 2018, 17 (04) : 391 - 398
  • [6] Large-vessel involvement in giant cell arteritis
    Bongartz, T
    Matteson, EL
    CURRENT OPINION IN RHEUMATOLOGY, 2006, 18 (01) : 10 - 17
  • [7] Large-vessel involvement is predictive of multiple relapses in giant cell arteritis
    de Mornac, Donatienne
    Espitia, Olivier
    Neel, Antoine
    Connault, Jerome
    Masseau, Agathe
    Espitia-Thibault, Alexandra
    Artifoni, Mathieu
    Achille, Aurelie
    Wahbi, Anais
    Lacou, Mathieu
    Durant, Cecile
    Pottier, Pierre
    Perrin, Francois
    Graveleau, Julie
    Hamidou, Mohamed
    Hardouin, Jean-Benoit
    Agard, Christian
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2021, 13
  • [8] Association between the patterns of large-vessel lesions and treatment outcomes in patients with large-vessel giant cell arteritis
    Sugihara, Takahiko
    Uchida, Haruhito A.
    Yoshifuji, Hajime
    Maejima, Yasuhiro
    Naniwa, Taio
    Katsumata, Yasuhiro
    Okazaki, Takahiro
    Ishizaki, Jun
    Murakawa, Yohko
    Ogawa, Noriyoshi
    Dobashi, Hiroaki
    Horita, Tetsuya
    Tanaka, Yoshiya
    Furuta, Shunsuke
    Takeuchi, Tsutomu
    Komagata, Yoshinori
    Nakaoka, Yoshikazu
    Harigai, Masayoshi
    MODERN RHEUMATOLOGY, 2023, 33 (06) : 1145 - 1153
  • [9] Prognosis of large-vessel giant cell arteritis
    Schmidt, W. A.
    Moll, A.
    Seifert, A.
    Schicke, B.
    Gromnica-Ihle, E.
    Krause, A.
    RHEUMATOLOGY, 2008, 47 (09) : 1406 - 1408
  • [10] The current place of non-invasive large-vessel imaging in the diagnosis and follow-up of giant cell arteritis
    Liozon, E.
    REVUE DE MEDECINE INTERNE, 2020, 41 (11): : 756 - 768